HSIC Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $84.88
Kapitalisasi Pasar (MRQ) $9.50B
P/E (TTM) 24.7
EPS (TTM) $3.43
Pendapatan (TTM) $13.60B
ROE (TTM) 12.2%
D/E Utang/Ekuitas (MRQ) 0.3
Rentang 52M $62–$92

HSIC Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Pemecahan saham 3
Tanggal ex-dividen Pemecahan Tipe
8 Feb. 2019 51-for-40 Maju
15 Sep. 2017 2-for-1 Maju
1 Maret 2005 2-for-1 Maju

Tentang Henry Schein, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.

History

In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.

In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.

Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.

In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.

Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.

In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.

In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.

Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.

In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.

In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.

In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.

On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.

In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.

In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.

Operations

Dental

In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.

Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.

Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.

In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.

In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.

In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.

In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.

In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.

In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.

In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.

Henry Schein One

In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.

In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.

In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.

In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.

Medical

In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.

In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.

In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.

In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.

In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).

In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).

Former division

Animal health

Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.

Philanthropy

In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.

Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.

In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.

Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.

In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.

Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.

In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealth Care industriHealth Care karyawan25.000 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
Pendapatan$13.18B
2016-12-31 → 2025-12-27
EPS$3.27
2016-12-31 → 2025-12-27
Arus Kas Bebas$573M
2016-12-31 → 2025-12-27
Margin bersih3.0%
2016-12-31 → 2025-12-27
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun HSIC rata-rata 5T Median Rekan Kesimpulan
P/E (TTM) 24.7rata-rata 5T ≈21.5 ≈21.5 22.9 Terlalu mahal
P/S (TTM) 0.7rata-rata 5T ≈0.8 ≈0.8 0.5 Terlalu mahal
P/B (MRQ) 3.0rata-rata 5T ≈2.8 ≈2.8 · ·
EV / EBITDA 10.7rata-rata 5T ≈10.4 ≈10.4 · ·
Harga / FCF (TTM) 16.7rata-rata 5T ≈18.5 ≈18.5 · ·
Harga / Arus Kas (TTM) 13.6rata-rata 5T ≈14.8 ≈14.8 14.0 Nilai wajar
EV / Revenue (EV / Pendapatan) 0.8rata-rata 5T ≈0.8 ≈0.8 · ·
EV / FCF 18.0rata-rata 5T ≈18.9 ≈18.9 · ·
Harga / Nilai Buku Berwujud (MRQ) 4.3 · · ·
PEG Ratio (Rasio PEG) ≈8.2 · · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Kejutan Rata-rata 0.97%
Laporan Berikutnya Nov 02, 2026
PeriodeLaporanEPS AktualEPS EstimasiKejutan
30 Juni 2026 Agu 11, 2026 $1.27 $1.26 0.67%
31 Maret 2026 Mei 12, 2026 $1.32 $1.24 6.3%
31 Des. 2025 $1.34 $1.33 1.1%
30 Sep. 2025 $1.38 $1.30 5.8%
30 Juni 2025 $1.10 $1.22 -9.5%
31 Maret 2025 $1.15 $1.13 1.6%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 17
Metrik Tren 20252024202320222021202020192018201720162015
Revenue $13.18B$12.67B$12.34B$12.65B$12.40B$10.12B$9.99B$9.42B$8.88B$11.57B$10.63B
Cost of Revenue $9.08B$8.66B$8.48B$8.82B$8.73B$7.30B$6.89B$6.51B$6.14B$8.35B$7.62B
Gross Profit $4.11B$4.02B$3.86B$3.83B$3.67B$2.82B$3.09B$2.91B$2.75B$3.23B$3.01B
SG&A Expense $3.08B$3.03B$2.96B$2.77B$2.63B$2.09B$2.36B$2.22B$2.07B$2.41B$2.24B
Operating Expenses ·······$2.70B$2.53B$2.41B·
Operating Income $653M$621M$615M$747M$852M$535M$718M$601M$670M$772M$734M
Interest Expense $150M$131M$87M$35M$27M$41M$51M$76M$51M$32M$26M
Interest Income $33M$24M$17M$8M$6M$10M$16M$15M$12M$13M$13M
Other Non-op $-3M$-1M$-3M$1M$0$-4M$-3M$-3M$-1M$3M$-141.0K
Pretax Income $533M$513M$542M$721M$831M$500M$680M$537M$630M$756M$721M
Income Tax $126M$128M$120M$170M$198M$95M$160M$107M$309M$218M$211M
Net Income $398M$390M$416M$538M$631M$404M$695M$536M$406M$507M$479M
EPS (Basic) $3.29$3.07$3.18$3.95$4.51$2.83$4.70$3.51$2.59$3.14$2.89
EPS (Diluted) $3.27$3.05$3.16$3.91$4.45$2.82$4.65$3.49$2.57$3.10$2.85
Shares (Basic) 120,813,977126,788,997130,618,990136,064,221140,090,889142,504,193147,817,000152,656,000156,787,000161,641,000165,687,000
Shares (Diluted) 121,717,876127,779,228131,748,171137,755,670141,772,781143,403,682149,257,000153,707,000158,208,000163,723,000168,250,000
EBITDA $964M$918M$863M$959M$1.06B$721M$903M$961M·$941M$893M
Neraca 26
Metrik Tren 20252024202320222021202020192018201720162015
Cash & Equivalents $156M$122M$171M$117M$118M$421M·$57M$158M$62M$72M
Receivables $1.65B$1.48B$1.86B$1.44B$1.45B$1.42B$1.25B$1.17B$1.52B$1.25B$1.23B
Inventory $2.00B$1.81B$1.81B$1.96B$1.86B$1.51B$1.43B$1.42B$1.93B$1.67B$1.51B
Prepaid Expense $655M$569M$639M$466M$413M$433M$445M$451M$455M$361M$361M
Current Assets $4.46B$3.98B$4.49B$3.99B$3.84B$3.79B$3.23B$4.18B$4.09B$3.34B$3.23B
PP&E (Net) ····$366M$342M$330M$314M$375M$334M$318M
PP&E (Gross) $1.38B$1.20B$1.17B$956M$916M$868M$799M$905M$990M$865M$797M
Accum. Depreciation $759M$670M$672M$573M$550M$526M$469M$591M$615M$531M$478M
Goodwill $4.21B$3.89B$3.88B$2.89B$2.85B$2.50B$2.46B$2.08B$1.55B$2.02B$1.91B
Intangibles $1.02B$1.02B$916M$587M$668M$479M$573M$376M$670M$621M$593M
Total Assets $11.21B$10.22B$10.57B$8.61B$8.48B$7.77B$7.15B$8.50B$7.86B$6.81B$6.53B
Accounts Payable $1.15B$962M$1.02B$1.00B$1.05B$1.01B$880M$786M$1.15B$1.01B$1.01B
Short-term Debt $764M$650M$264M$103M$51M$73M$24M$951M···
Current Liabilities $3.23B$2.80B$2.68B$2.22B$2.31B$2.28B$2.04B$3.22B$2.83B$2.32B$2.15B
Capital Leases $251M$259M$310M$275M$268M$239M$176M$0···
Deferred Tax $146M$102M$54M$36M$42M$30M$65M$27M$50M$52M$253M
Other Non-current Liabilities $486M$387M$436M$361M$377M$393M$331M$358M$420M$264M$212M
Total Liabilities $6.42B$5.38B$5.42B$3.94B$3.81B$3.46B$3.23B$4.65B$4.21B$3.35B$3.08B
Long-term Debt ···$1.05B$822M······
Total Debt $764M$650M$264M$103M$51M$73M$24M····
Paid-in Capital $177M$0$0$0$0$0$48M$0···
Retained Earnings $3.29B$3.77B$3.86B$3.68B$3.60B$3.45B$3.12B$3.21B$2.94B$2.98B$2.90B
AOCI $-226M$-379M$-206M$-233M$-171M$-108M$-167M$-249M$-130M$-317M$-220M
Stockholders' Equity $3.25B$3.39B$3.65B$3.45B$3.42B$3.35B$3.00B$2.96B$2.81B$2.79B$2.88B
Liabilities + Equity $11.21B$10.22B$10.57B$8.61B$8.48B$7.77B$7.15B$8.50B$7.86B$6.76B$6.50B
Shares Outstanding 115,771,149124,155,884129,247,765131,792,817137,145,558142,462,571143,353,459151,401,668153,690,146158,805,010164,830,640
Arus Kas 19
Metrik Tren 20252024202320222021202020192018201720162015
D&A $311M$297M$248M$212M$210M$186M$185M$144M$134M$170M$159M
Stock-based Comp $39M$39M$39M$54M$78M$9M$45M$33M$37M$58M$45M
Deferred Tax $5M$-61M$-20M$-73M$-11M$-53M$-4M$-25M$1M$-37M$-6M
Amort. of Intangibles $180M$185M$152M$126M$124M$106M$108M$75M$70M$98M$93M
Restructuring $105M$110M$80M$128M$8M··$54M$0$46M$35M
Other Non-cash $-41M$183M$-183M$-129M$-199M$54M$-266M$-54M·$-82M$-90M
Operating Cash Flow $712M$848M$500M$602M$710M$599M$654M$685M$546M$643M$616M
CapEx $139M$148M$147M$96M$79M$49M$76M$71M$62M$70M$72M
Investing Cash Flow $-400M$-430M$-1.14B$-276M$-677M$-115M$-424M$-193M$-342M$-316M$-260M
Debt Issued $489M$120M$1.37B$270M$305M$501M$741.0K$115M$200M$261M$135M
Net Debt Issued $445M$-198M$900M$211M$183M$-110M$-260M$87M·$245M$-66M
Stock Issued $250M$0$0········
Stock Repurchased $850M$385M$250M$485M$401M$74M$525M$200M$450M$550M$300M
Net Stock Activity $-600M$-385M$-250M$-485M$-401M$-74M$-525M$-200M·$-550M$-300M
Financing Cash Flow $-188M$-510M$701M$-315M$-333M$-187M$-216M$-604M$-113M$-327M$-348M
Net Change in Cash $34M$-49M$54M$-1M$-303M$315M$26M$-94M$225M$-10M$-17M
Taxes Paid $128M··········
Free Cash Flow $573M$700M$353M$506M$631M$550M$578M$594M·$545M$515M
Levered FCF $458M$602M$285M$472M$610M$517M$539M$533M·$523M$497M
Profitabilitas 8
Metrik Tren 20252024202320222021202020192018201720162015
Gross Margin 31.1%31.7%31.3%30.3%29.6%27.8%30.9%27.2%·28.0%28.3%
Operating Margin 5.0%4.9%5.0%5.9%6.9%5.3%7.2%5.7%·6.7%6.9%
Net Margin 3.0%3.1%3.4%4.2%5.1%4.0%7.0%4.1%·4.4%4.5%
Pretax Margin 4.0%4.0%4.4%5.7%6.7%4.9%6.8%5.3%·6.5%6.8%
EBITDA Margin 7.3%7.2%7.0%7.6%8.6%7.1%9.0%7.3%·8.1%8.4%
ROA 3.7%3.8%4.3%6.3%7.8%5.4%8.9%6.6%·7.6%7.6%
ROE 12.0%11.1%11.7%15.7%18.6%12.7%23.3%18.6%·17.8%16.8%
ROIC 12.4%11.5%12.2%16.1%18.7%12.7%18.2%19.7%·19.7%18.0%
Likuiditas & Solvabilitas 4
Metrik Tren 20252024202320222021202020192018201720162015
Current Ratio 1.41.41.71.81.71.71.61.3·1.41.5
Quick Ratio 0.60.60.80.70.70.60.60.5·0.60.6
Debt / Equity 0.20.20.10.00.00.00.0····
Interest Coverage 4.44.77.117.030.912.914.19.6·24.228.2
Efisiensi 3
Metrik Tren 20252024202320222021202020192018201720162015
Asset Turnover 1.21.21.31.51.51.41.31.6·1.71.7
Inventory Turnover 4.84.84.54.65.25.04.84.9·5.35.4
Receivables Turnover 8.47.67.58.78.67.68.38.4·9.39.0
Per Saham 5
Metrik Tren 20252024202320222021202020192018201720162015
Book Value / Share $28.03$27.33$28.28$26.15$24.97$23.50$20.91$19.56·$35.18$35.00
Revenue / Share $108.32$99.18$93.66$91.81$87.47$70.56$66.90$85.89·$141.36$126.36
Cash Flow / Share $5.85$6.64$3.80$4.37$5.00$4.18$4.38$4.45·$7.52$6.98
Cash / Share $1.35$0.98$1.32$0.89$0.86··$0.53·$0.79$0.87
EPS (TTM) $3.27$3.05$3.16$3.91$4.45$2.82$4.65$3.49·$3.10$2.85
Tingkat Pertumbuhan 9
Metrik Tren 20252024202320222021202020192018201720162015
Revenue YoY 4.0%2.7%-2.4%2.0%22.6%······
Revenue CAGR 3Y 1.4%0.73%6.8%········
Revenue CAGR 5Y 5.4%··········
EPS YoY 7.2%-3.5%-19.2%-12.1%57.8%······
EPS CAGR 3Y -5.8%-11.8%3.9%········
EPS CAGR 5Y 3.0%··········
Net Income YoY 2.1%-6.2%-22.7%-14.7%56.2%······
Net Income CAGR 3Y -9.6%-14.8%0.98%········
Net Income CAGR 5Y -0.30%··········
Valuasi (TTM) 14
Metrik Tren 20252024202320222021202020192018201720162015
Revenue TTM $13.18B$12.67B$12.34B$12.65B$12.40B$10.12B$9.99B$9.42B·$11.57B$10.63B
Net Income TTM $398M$390M$416M$538M$631M$404M$695M$536M·$507M$479M
Market Cap $8.81B$8.74B$9.79B$10.53B$10.28B$9.38B$9.54B$9.25B·$4.72B$5.08B
Enterprise Value $9.42B$9.27B$9.88B$10.51B$10.21B······
P/E 23.323.124.020.416.823.314.317.5·19.221.6
P/S 0.70.70.80.80.80.91.01.0·0.40.5
P/B 2.72.62.73.13.02.83.23.1·1.71.8
P / Tangible Book ·····25.7·····
P / Cash Flow 12.410.319.617.514.515.714.613.5·7.78.7
P / FCF 15.412.527.720.816.317.016.515.6·8.79.9
EV / EBITDA 9.810.111.411.09.6······
EV / FCF 16.413.228.020.816.2······
EV / Revenue 0.70.70.80.80.8······
Earnings Yield 4.3%4.3%4.2%4.9%5.9%4.3%7.0%5.7%·5.2%4.6%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2025-12-272024-12-282023-12-302022-12-312021-12-25
Pendapatan $13.18B $12.67B $12.34B $12.65B $12.40B
Margin Kotor % 31.1% 31.7% 31.3% 30.3% 29.6%
Margin Operasi % 5.0% 4.9% 5.0% 5.9% 6.9%
Laba Bersih $398M $390M $416M $538M $631M
EPS Dilusian $3.27 $3.05 $3.16 $3.91 $4.45

Pemilik institusional (13F) 600 pengaju · $11.2B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 600
Nilai yang dipegang $11.2B
Posisi baru 64
Posisi yang keluar 60
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
64 (-16 vs Kuartal sebelumnya) 60 (+14 vs Kuartal sebelumnya) 173 (-3 vs Kuartal sebelumnya) 220 (+25 vs Kuartal sebelumnya) +9.1M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
Kohlberg Kravis Roberts & Co. L.P. $1.307.257.713 15.652.032 11,68% Saham
VANGUARD GROUP INC $875.836.080 11.588.199 7,82% Saham
FMR LLC $630.901.802 7.553.901 5,64% Saham
BlackRock, Inc. $586.699.894 7.024.663 5,24% Saham
Artisan Partners Limited Partnership $540.162.844 6.467.467 4,82% Saham
VANGUARD CAPITAL MANAGEMENT LLC $530.073.795 6.346.669 4,73% Saham
JPMORGAN CHASE & CO $366.432.667 4.342.929 3,27% Saham
STATE STREET CORP $359.576.652 4.305.276 3,21% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $345.225.076 4.133.442 3,08% Saham
AMERICAN CENTURY COMPANIES INC $288.743.396 3.457.175 2,58% Saham
DIMENSIONAL FUND ADVISORS LP $283.495.786 3.394.242 2,53% Saham
Southpoint Capital Advisors LP $275.616.000 3.300.000 2,46% Saham
Invesco Ltd. $263.107.794 3.150.237 2,35% Saham
CITADEL ADVISORS LLC $243.970.523 2.921.103 2,18% Saham
GEODE CAPITAL MANAGEMENT, LLC $227.537.373 2.729.030 2,03% Saham
Palestra Capital Management LLC $204.347.632 2.446.691 1,83% Saham
BANK OF MONTREAL /CAN/ $176.687.394 2.115.510 1,58% Saham
MORGAN STANLEY $175.460.572 2.100.819 1,57% Saham
FIDUCIARY MANAGEMENT INC /WI/ $151.785.323 1.817.353 1,36% Saham
Burgundy Asset Management Ltd. $151.049.204 2.170.871 1,35% Saham
LYRICAL ASSET MANAGEMENT LP $122.553.156 1.467.351 1,09% Saham
UBS Group AG $111.653.127 1.336.843 1,00% Saham
Swedbank AB $109.479.854 1.310.822 0,98% Saham
M.D. Sass, LLC $107.485.396 1.286.942 0,96% Saham
SNYDER CAPITAL MANAGEMENT L P $107.341.992 1.285.225 0,96% Saham
SCHRODER INVESTMENT MANAGEMENT GROUP $107.262.144 1.272.537 0,96% Saham
NORGES BANK $103.383.729 1.237.832 0,92% Saham
BANK OF AMERICA CORP /DE/ $101.266.079 1.212.477 0,90% Saham
GOLDMAN SACHS GROUP INC $98.070.544 1.174.216 0,88% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $86.593.118 1.036.795 0,77% Saham
NORTHERN TRUST CORP $80.548.694 964.424 0,72% Saham
NOMURA HOLDINGS INC $77.065.658 922.721 0,69% Saham
PZENA INVESTMENT MANAGEMENT LLC $71.888.420 860.733 0,64% Saham
DME Capital Management, LP $60.013.296 718.550 0,54% Saham
Ananym Capital Management, LP $57.978.164 694.183 0,52% Saham
Ulysses Management LLC $55.570.700 665.358 0,50% Saham
STALEY CAPITAL ADVISERS INC $55.252.489 661.548 0,49% Saham
VANGUARD FIDUCIARY TRUST CO $45.489.502 544.654 0,41% Saham
RAYMOND JAMES FINANCIAL INC $42.948.907 514.235 0,38% Saham
Bank of New York Mellon Corp $42.261.071 505.999 0,38% Saham
Nuveen, LLC $38.262.099 458.119 0,34% Saham
DEUTSCHE BANK AG\ $36.574.075 437.908 0,33% Saham
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $35.970.895 430.686 0,32% Saham
Clarkston Capital Partners, LLC $35.168.100 421.074 0,31% Saham
LONE PEAK GLOBAL INVESTORS LLC $33.404.158 399.954 0,30% Saham
GAMCO INVESTORS, INC. ET AL $30.537.668 365.633 0,27% Saham
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $27.342.332 370.995 0,24% Saham
PRIVATE MANAGEMENT GROUP INC $27.285.483 326.694 0,24% Saham
FRANKLIN RESOURCES INC $25.575.244 306.217 0,23% Saham
BNP PARIBAS FINANCIAL MARKETS $25.194.142 301.654 0,23% Saham

Tampilkan semua 600 pemilik institusional →

Aktivis & pemilik 5%+ 2 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 pengajuan 10 Maret 2026 16,40% Amandemen · SEC
KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 pengajuan 8 Agu 2025 13,00% Amandemen · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 52 orang dalam · 25 pejabat · 22 direktur

19
Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Andrea Albertini CEO, Global Dist. & Tech. 8 Sep. 2026 D 116.104 0 0 $0
Thomas C Popeck CEO, Henry Schein Products 19 Maret 2026 S 86.182 0 1 $-98.630
Frederick M. Lowery CEO 6 Maret 2026 A 95.156 0 0 $0
Bradford C Connett CEO, NA Distribution Group 19 Maret 2025 S 62.688 0 0 $0
David B Brous Jr CEO, Strategic Business Group 12 Juni 2023 S 68.690 0 0 $0
Karen Prange EVP&CEO Gl.AH.Med.Den.Sur.Grp 2 Maret 2018 A 62.902 0 0 $0
Lonnie Shoff CEO, Global Strat Port Grp 15 Maret 2016 S 31.000 0 0 $0
Ronald N. South SVP & Chief Financial Officer 16 Maret 2026 F 88.930 0 0 $0
James P Breslawski President 14 Maret 2025 D 200.227 0 0 $0
Bridget A Ross President, Global Medical Grp 6 Maret 2017 A 9.654 0 0 $0
Michael Zack President of Int'l Group 7 Maret 2013 M 48.716 0 0 $0
Michael S Ettinger EVP & Chief Operating Officer 17 Maret 2026 G 112.208 0 0 $0
Christine Zayac Sheehy SVP, Chief Human Res. Officer 16 Maret 2026 F 18.454 0 0 $0
Mark E Mlotek EVP, Chief Strategic Officer 16 Maret 2026 F 98.372 0 2 $-478.758
Walter Siegel Sr. VP & Chief Legal Officer 14 Maret 2025 D 43.191 0 0 $0
Lorelei Mcglynn SVP, Chief Human Res. Officer 6 Sep. 2024 S 71.833 0 0 $0
Gerald A Benjamin EVP, Chief Admin. Officer 26 Mei 2022 S 95.616 0 0 $0
David Mckinley CCO&Pres. Corp. Com. Dev. Grp. 30 Nov. 2018 S 68.012 0 0 $0
Paul Rose SVP, Global Supply Chain 6 Sep. 2017 S 17.841 0 0 $0
Robert Minowitz Pres., Int'l Dental Group EMEA 12 Mei 2017 S 22.943 0 0 $0
Michael Racioppi SVP Chief Merchandising Offic. 20 Maret 2017 M 23.088 0 0 $0
Peter M. Mccarthy Pres., Global Animal Health 13 Maret 2017 S 14.277 0 0 $0
James A. Harding SVP, Chief Technology Officer 8 Maret 2017 S 16.589 0 0 $0
Stanley Komaroff Senior Advisor 2 Maret 2016 F 25.144 0 0 $0
Leonard A David SVP, Chief Compliance Officer 17 Maret 2015 S 12.343 0 0 $0
William K Daniel Direktur 12 Juni 2026 A 7.641 1 0 $691.900
Scott Philip Serota Direktur 6 Maret 2026 A 10.790 0 0 $0
Carole T Faig Direktur 6 Maret 2026 A 8.025 0 0 $0
Anne H. Margulies Direktur 6 Maret 2026 A 23.153 0 0 $0
Mohamad Ali Direktur 6 Maret 2026 A 15.075 0 0 $0
Reed Vaughn Tuckson Direktur 6 Maret 2026 A 12.520 0 0 $0
Robert J. Hombach Direktur 6 Maret 2026 A 5.421 0 0 $0
Bradley T Sheares Direktur 6 Maret 2026 A 47.623 0 0 $0
Philip A Laskawy Direktur 6 Maret 2026 A 24.538 0 1 $-228.544
Carol Raphael Direktur 21 Mei 2025 F 33.538 0 0 $0
Steven Paladino Direktur 4 Maret 2024 A 138.272 0 0 $0
Dianne E Rekow Direktur 16 Maret 2022 A 18.526 0 0 $0
Barry J Alperin Direktur 16 Maret 2022 A 52.473 0 0 $0
Paul Brons Direktur 3 Maret 2021 F 16.854 0 0 $0
Shira Goodman Direktur 3 Maret 2021 A 5.689 0 0 $0
Lawrence S Bacow Direktur 6 Maret 2018 F 10.115 0 0 $0
Donald J Kabat Direktur 6 Maret 2018 F 10.874 0 0 $0
Louis W Sullivan Direktur 31 Maret 2016 A 14.096 0 0 $0
Norman S Matthews Direktur 31 Maret 2016 A 12.890 0 0 $0
Karyn Mashima Direktur 10 Maret 2014 F 19.269 0 0 $0
Irving Shafran Direktur 20 Nov. 2003 S 750.000 0 0 $0
Stanley M Bergman · 26 Mei 2026 G 253.279 0 5 $-7.544.687
Kurt P Kuehn · 10 Maret 2026 S 15.420 0 1 $-224.562
Deborah Derby · 6 Maret 2026 A 15.093 0 0 $0
Joseph L Herring · 6 Maret 2026 A 30.325 0 0 $0
Margaret A Hamburg · 20 Mei 2009 M 0 0 0 $0
Pamela Joseph · 16 Nov. 2004 S 98.879 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 86 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
RSPH · Invesco Exchange-Traded Fund Trust 1,56% 162.140 SH 1 Okt. 2026 Harian
GURU · Global X Funds 1,29% 9.179 NS 31 Juli 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 0,87% 106.077 NS 31 Juli 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 0,64% 125.073 SH 1 Okt. 2026 Harian
FBCV · FIDELITY COVINGTON TRUST 0,36% 7.509 NS 31 Juli 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,33% 18.150 NS 31 Juli 2026 N-PORT
IQSM · New York Life Investments ETF Trust 0,33% 12.855 NS 31 Juli 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 0,28% 54.791 SH 1 Okt. 2026 Harian
BKMC · BNY Mellon ETF Trust 0,23% 17.140 NS 31 Juli 2026 N-PORT
DFAT · Dimensional ETF Trust 0,22% 364.767 NS 31 Juli 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,20% 57.583 NS 31 Juli 2026 N-PORT
RSP · Invesco Exchange-Traded Fund Trust 0,20% 2.223.555 SH 1 Okt. 2026 Harian
DFAS · Dimensional ETF Trust 0,19% 343.006 NS 31 Juli 2026 N-PORT
ESML · iShares Trust 0,18% 58.607 SH 11 Sep. 2026 Harian
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0,17% 41.019 NS 31 Juli 2026 N-PORT
VBR · VANGUARD INDEX FUNDS 0,17% 1.416.056 SH 19 Agu 2026 Harian
FNX · First Trust Exchange-Traded AlphaDE… 0,15% 24.666 NS 31 Juli 2026 N-PORT
FNK · First Trust Exchange-Traded AlphaDE… 0,15% 3.879 NS 31 Juli 2026 N-PORT
IYH · iShares Trust 0,14% 57.526 SH 11 Sep. 2026 Harian
NUSC · Nushares ETF Trust 0,14% 20.654 NS 31 Juli 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,12% 46.652 NS 31 Juli 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,12% 293.098 SH 19 Agu 2026 Harian
SMMD · iShares Trust 0,12% 52.697 SH 11 Sep. 2026 Harian
IXJ · iShares Trust 0,11% 51.636 SH 11 Sep. 2026 Harian
VB · VANGUARD INDEX FUNDS 0,10% 2.230.411 SH 19 Agu 2026 Harian
CURE · Direxion Shares ETF Trust 0,10% 1.905 NS 31 Juli 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0,09% 8.644 SH 1 Okt. 2026 Harian
VFMF · VANGUARD WELLINGTON FUND 0,09% 7.550 SH 19 Agu 2026 Harian
IWS · iShares Trust 0,08% 146.411 SH 10 Sep. 2026 Harian
TILT · FlexShares Trust 0,08% 20.224 NS 31 Juli 2026 N-PORT
WSML · iShares Trust 0,08% 6.020 SH 11 Sep. 2026 Harian
VFVA · VANGUARD WELLINGTON FUND 0,07% 7.214 SH 19 Agu 2026 Harian
RWL · Invesco Exchange-Traded Fund Trust … 0,07% 77.197 SH 1 Okt. 2026 Harian
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,07% 6.494 NS 31 Juli 2026 N-PORT
IWR · iShares Trust 0,06% 403.437 SH 11 Sep. 2026 Harian
DFUV · Dimensional ETF Trust 0,06% 98.929 NS 31 Juli 2026 N-PORT
DFSU · Dimensional ETF Trust 0,05% 13.423 NS 31 Juli 2026 N-PORT
XOEF · iShares Trust 0,05% 125 SH 11 Sep. 2026 Harian
DFAC · Dimensional ETF Trust 0,05% 270.764 NS 31 Juli 2026 N-PORT
DXUV · Dimensional ETF Trust 0,05% 2.999 NS 31 Juli 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0,04% 5.039 SH 1 Okt. 2026 Harian
FAB · First Trust Exchange-Traded AlphaDE… 0,04% 858 NS 31 Juli 2026 N-PORT
CATH · Global X Funds 0,04% 6.000 NS 31 Juli 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,04% 44.360 SH 1 Okt. 2026 Harian
DCOR · Dimensional ETF Trust 0,03% 13.104 NS 31 Juli 2026 N-PORT
VOOV · VANGUARD ADMIRAL FUNDS 0,03% 22.387 SH 19 Agu 2026 Harian
IVE · iShares Trust 0,03% 160.669 SH 11 Sep. 2026 Harian
IUSV · iShares Trust 0,03% 83.684 SH 11 Sep. 2026 Harian
CHRI · Global X Funds 0,03% 24 NS 31 Juli 2026 N-PORT
DSI · iShares Trust 0,02% 14.799 SH 10 Sep. 2026 Harian
IWD · iShares Trust 0,02% 218.760 SH 11 Sep. 2026 Harian
VONV · VANGUARD SCOTTSDALE FUNDS 0,02% 59.466 SH 19 Agu 2026 Harian
EGLE · Global X Funds 0,02% 5 NS 31 Juli 2026 N-PORT
DFAU · Dimensional ETF Trust 0,02% 25.929 NS 31 Juli 2026 N-PORT
XYLG · Global X Funds 0,02% 132 NS 31 Juli 2026 N-PORT
TOPC · iShares Trust 0,02% 59 SH 10 Sep. 2026 Harian
QVML · Invesco Exchange-Traded Fund Trust … 0,02% 3.104 SH 1 Okt. 2026 Harian
XCLR · Global X Funds 0,01% 6 NS 31 Juli 2026 N-PORT
XVV · iShares Trust 0,01% 1.104 SH 11 Sep. 2026 Harian
PTLC · Pacer Funds Trust 0,01% 5.070 NS 31 Juli 2026 N-PORT
IVV · iShares Trust 0,01% 1.220.662 SH 11 Sep. 2026 Harian
XYLD · Global X Funds 0,01% 4.788 NS 31 Juli 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,01% 576 SH 1 Okt. 2026 Harian
DFUS · Dimensional ETF Trust 0,01% 30.222 NS 31 Juli 2026 N-PORT
IWB · iShares Trust 0,01% 68.043 SH 11 Sep. 2026 Harian
XRMI · Global X Funds 0,01% 70 NS 31 Juli 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,01% 365 NS 31 Juli 2026 N-PORT
IWV · iShares Trust 0,01% 27.083 SH 9 Sep. 2026 Harian
IYY · iShares Trust 0,01% 4.036 SH 10 Sep. 2026 Harian
QDPL · Pacer Funds Trust 0,01% 2.304 NS 31 Juli 2026 N-PORT
ITOT · iShares Trust 0,01% 123.729 SH 11 Sep. 2026 Harian
PHDG · Invesco Actively Managed Exchange-T… 0,01% 77 SH 1 Okt. 2026 Harian
HCMT · Direxion Shares ETF Trust 0,01% 674 NS 31 Juli 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,01% 2.513.394 SH 19 Agu 2026 Harian
VTI · VANGUARD INDEX FUNDS 0,01% 3.089.160 SH 19 Agu 2026 Harian
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 81.658 SH 19 Agu 2026 Harian
VONE · VANGUARD SCOTTSDALE FUNDS 0,01% 16.261 SH 19 Agu 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 0,01% 8.309 SH 19 Agu 2026 Harian
ESGV · VANGUARD WORLD FUND 0,01% 22.281 SH 19 Agu 2026 Harian
SPXL · Direxion Shares ETF Trust 0,01% 7.569 NS 31 Juli 2026 N-PORT
XTR · Global X Funds 0,01% 4 NS 31 Juli 2026 N-PORT
DFSV · Dimensional ETF Trust 0,00% 99 NS 31 Juli 2026 N-PORT
ISCB · iShares Trust · 4.208 SH 11 Sep. 2026 Harian
ISCV · iShares Trust · 20.757 SH 11 Sep. 2026 Harian
SMLF · iShares Trust · 8.316 SH 11 Sep. 2026 Harian
SMMV · iShares Trust · 19.508 SH 19 Agu 2026 Harian

HSIC Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 25 analis BELI
Target median $100.00 +17,8%
7 28,0% Beli Kuat
8 32,0% Beli
9 36,0% Tahan
1 4,0% Jual
0 0,0% Jual Kuat

Target Harga 12 Bulan

15 analis · 2026-09-30

Target rata-rata $97.27 +14,6%

Sekarang Harga saat ini $84.88
Rendah$64.00 Rata-rata$97.27 Tinggi$110.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
HSIC $8.81B 23.3 4.0% 3.0% 12.0% 31.1%
MCK $242.30B 22.5 12.4% 1.2% -224.3% 3.6%
COR $60.61B 39.3 9.3% 0.48% 144.3% 3.6%
CAH · 32.9 14.2% 0.67% -60.5% 3.8%
AHCO $1.35B -19.2 -0.49% -2.2% -4.6% ·
ACH · · · · · ·
MEDS · · · · · ·

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan

25

Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 10-Q diajukan Agu 4, 2026